Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Yoganand, Chillarige"'
Autor:
Rachel P. Ogilvie, J. Bradley Layton, Patricia C. Lloyd, Yixin Jiao, Djeneba Audrey Djibo, Hui Lee Wong, Joann F. Gruber, Ron Parambi, Jie Deng, Michael Miller, Jennifer Song, Lisa B. Weatherby, Lauren Peetluk, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Christine L. Bui, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, Grace Yang, Kandace L. Amend, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Mary S. Anthony, John D. Seeger, Azadeh Shoaibi
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background COVID-19 vaccines are authorized for use in children in the United States; real-world assessment of vaccine effectiveness in children is needed. This study’s objective was to estimate the effectiveness of receiving a complete pr
Externí odkaz:
https://doaj.org/article/a71040a255aa47ef99a2668dec27e3e6
Autor:
J. Bradley Layton, Lauren Peetluk, Hui Lee Wong, Yixin Jiao, Djeneba Audrey Djibo, Christine Bui, Patricia C. Lloyd, Joann F. Gruber, Michael Miller, Rachel P. Ogilvie, Jie Deng, Ron Parambi, Jennifer Song, Lisa B. Weatherby, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, John D. Seeger, Grace Wenya Yang, Dóra Illei, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Kandace L. Amend, Mary S. Anthony, Azadeh Shoaibi
Publikováno v:
Vaccine: X, Vol 16, Iss , Pp 100447- (2024)
Background: Monovalent booster/additional doses of COVID-19 vaccines were first authorized in August 2021 in the United States. We evaluated the real-world effectiveness of receipt of a monovalent booster/additional dose of COVID-19 vaccine compared
Externí odkaz:
https://doaj.org/article/24a425573ed6479eb8e9ad2ca557699a
Autor:
Perez-Vilar, Silvia (AUTHOR) silvia.perezvilar@fda.hhs.gov, Kazemian, Sara (AUTHOR), Greene, Christina (AUTHOR), Duenas, Pablo Freyria (AUTHOR), Radin, Rose (AUTHOR), Lindaas, Arnstein (AUTHOR), Akhtar, Sandia (AUTHOR), Wernecke, Michael (AUTHOR), Chillarige, Yoganand (AUTHOR), Kelman, Jeffrey A. (AUTHOR), Graham, David J. (AUTHOR)
Publikováno v:
American Journal of Public Health. 2024 Suppl 8, Vol. 114, pS694-S697. 4p.
Autor:
F. Scott Dahlgren, David K. Shay, Hector S. Izurieta, Richard A. Forshee, Michael Wernecke, Yoganand Chillarige, Yun Lu, Jeffrey A. Kelman, Carrie Reed
Publikováno v:
Epidemics, Vol 26, Iss , Pp 23-31 (2019)
Using Medicare claims data on prescriptions of oseltamivir dispensed to people 65 years old and older, we present a descriptive analysis of patterns of influenza activity in the United States for 579 core-based statistical areas (CBSAs) from the 2010
Externí odkaz:
https://doaj.org/article/793440d32107498da5950d1362c32156
Autor:
Yixin Jiao, Keran Moll, Graça M. Dores, Ellen Tworkoski, Cindy Ke Zhou, Dorothy Scott, Hui‐Lee Wong, Kathryn Fingar, Timothy Burrell, Rowan McEvoy, Shayan Hobbi, Yoganand Chillarige, Joyce Obidi, Thomas MaCurdy, Jeffrey Kelman, Azadeh Shoaibi
Publikováno v:
Transfusion. 63:516-530
Autor:
Keran, Moll, Bradley, Lufkin, Kathryn R, Fingar, Cindy, Ke Zhou, Ellen, Tworkoski, Chianti, Shi, Shayan, Hobbi, Mao, Hu, Minya, Sheng, Jillian, McCarty, Shanlai, Shangguan, Timothy, Burrell, Yoganand, Chillarige, Jeff, Beers, Patrick, Saunders-Hastings, Stella, Muthuri, Kathryn, Edwards, Steven, Black, Jeff, Kelman, Christian, Reich, Kandace L, Amend, Djeneba Audrey, Djibo, Daniel, Beachler, Rachel P, Ogilvie, Alex, Secora, Cheryl N, McMahill-Walraven, John D, Seeger, Patricia, Lloyd, Deborah, Thompson, Rositsa, Dimova, Thomas, MaCurdy, Joyce, Obidi, Steve, Anderson, Richard, Forshee, Hui-Lee, Wong, Azadeh, Shoaibi
Publikováno v:
Vaccine. 41:333-353
The U.S. Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative conducts active surveillance of adverse events of special interest (AESI) after COVID-19 vaccination. Historical incidence rates (IRs) of AESI are compar
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
Autor:
Patricia C. Lloyd, Mao Hu, Hui-Lee Wong, Azadeh Shoaibi, Cindy Ke Zhou, An-Chi Lo, Kandace Amend, Daniel C. Beachler, Cheryl N. McMahill-Walraven, Elizabeth R. Smith, John Seeger, Alex Secora, Djeneba Audrey Djibo, Joyce Obidi, Yuhui Feng, Jennifer Song, Christian Reich, Charalynn Harris, Sandia Akhtar, Robin Clifford, Nandini Selvam, Jennifer L. Pigoga, Yixin Jiao, Yoganand Chillarige, Thomas MaCurdy, Richard Forshee, Steven A. Anderson
Publikováno v:
Vaccine. 40:6481-6488
Active monitoring of safety outcomes following COVID-19 vaccination is critical to understand vaccine safety and can provide early detection of rare outcomes not identified in pre-licensure trials. We present findings from an early warning rapid surv
Autor:
Mao Hu, Hui Lee Wong, Yuhui Feng, Patricia C. Lloyd, Elizabeth R. Smith, Kandace L. Amend, Annemarie Kline, Daniel C. Beachler, Joann F. Gruber, Mahasweta Mitra, John D. Seeger, Charlalynn Harris, Alex Secora, Joyce Obidi, Jing Wang, Jennifer Song, Cheryl N. McMahill-Walraven, Christian Reich, Rowan McEvoy, Rose Do, Yoganand Chillarige, Robin Clifford, Danielle D. Cooper, Azadeh Shoaibi, Richard Forshee, Steven A. Anderson
Publikováno v:
JAMA Pediatrics.
ImportanceActive monitoring of health outcomes after COVID-19 vaccination offers early detection of rare outcomes that may not be identified in prelicensure trials.ObjectiveTo conduct near–real-time monitoring of health outcomes following BNT162b2
Autor:
Yun Lu, Arnstein Lindaas, Hector S Izurieta, Myrna Cozen, Mikhail Menis, Xiangyu Shi, Whitney Steele, Michael Wernecke, Yoganand Chillarige, Jeffrey A Kelman, Richard A Forshee
This retrospective study utilized healthcare claims data to investigate the incidence, patient demographics, and concurrent diagnoses associated with long COVID in the U.S. Medicare population. Nearly 194,000 (0.6%) beneficiaries had post-COVID condi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b50d63a7f904815382e06569e292e8bc
https://doi.org/10.1101/2023.03.07.23286107
https://doi.org/10.1101/2023.03.07.23286107
Autor:
Azadeh Shoaibi, Patricia C. Lloyd, Hui-Lee Wong, Tainya C. Clarke, Yoganand Chillarige, Rose Do, Mao Hu, Yixin Jiao, Andrew Kwist, Arnstein Lindaas, Rowan McEvoy, Michelle Ondari, Shruti Parulekar, Xiangyu Shi, Jing Wang, Yun Lu, Joyce Obidi, Cindy K. Zhou, Jeffrey A. Kelman, Richard A. Forshee, Steven A. Anderson
BackgroundOur near-real-time safety monitoring of 16 adverse events (AEs) following COVID-19 mRNA vaccination identified potential elevations in risk for six AEs following primary series and monovalent booster dose administration. The crude associati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f6eb66a7250b47d1378b50edb5a77b9
https://doi.org/10.1101/2023.01.19.23284803
https://doi.org/10.1101/2023.01.19.23284803